Ming Ming Wen

696 total citations
18 papers, 536 citations indexed

About

Ming Ming Wen is a scholar working on Pharmaceutical Science, Molecular Biology and Dermatology. According to data from OpenAlex, Ming Ming Wen has authored 18 papers receiving a total of 536 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Pharmaceutical Science, 3 papers in Molecular Biology and 3 papers in Dermatology. Recurrent topics in Ming Ming Wen's work include Advancements in Transdermal Drug Delivery (5 papers), Advanced Drug Delivery Systems (4 papers) and RNA Interference and Gene Delivery (3 papers). Ming Ming Wen is often cited by papers focused on Advancements in Transdermal Drug Delivery (5 papers), Advanced Drug Delivery Systems (4 papers) and RNA Interference and Gene Delivery (3 papers). Ming Ming Wen collaborates with scholars based in Egypt, Saudi Arabia and Malaysia. Ming Ming Wen's co-authors include Amal H. El‐Kamel, Ragwa M. Farid, Amira Sayed Hanafy, Giovanni Tosi, María J. Blanco‐Prieto, Noha S. El-Salamouni, Heba A. Hazzah, Wessam M. El-Refaie, Nashiru Billa and Abeer Ahmed Kassem and has published in prestigious journals such as Journal of Controlled Release, International Journal of Nanomedicine and Pharmaceutics.

In The Last Decade

Ming Ming Wen

18 papers receiving 525 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ming Ming Wen Egypt 11 176 164 128 73 63 18 536
Guoguang Chen China 15 167 0.9× 192 1.2× 150 1.2× 63 0.9× 185 2.9× 31 626
Weigen Lu China 13 162 0.9× 260 1.6× 222 1.7× 83 1.1× 162 2.6× 29 768
Thomas Birngruber Austria 15 154 0.9× 156 1.0× 141 1.1× 44 0.6× 138 2.2× 48 781
Mayank Handa India 15 134 0.8× 124 0.8× 127 1.0× 54 0.7× 96 1.5× 33 531
Chengcheng Feng China 12 196 1.1× 228 1.4× 175 1.4× 59 0.8× 127 2.0× 22 601
Dnyandev Gadhave India 13 285 1.6× 199 1.2× 111 0.9× 59 0.8× 59 0.9× 25 550
Muhammad Wasim Khan Pakistan 8 184 1.0× 147 0.9× 116 0.9× 29 0.4× 61 1.0× 21 448
Susbin Raj Wagle Australia 14 127 0.7× 189 1.2× 74 0.6× 34 0.5× 47 0.7× 54 646
Qingfan Meng China 16 107 0.6× 305 1.9× 167 1.3× 35 0.5× 114 1.8× 28 638
Alexandra Bocsik Hungary 17 293 1.7× 240 1.5× 127 1.0× 72 1.0× 78 1.2× 26 860

Countries citing papers authored by Ming Ming Wen

Since Specialization
Citations

This map shows the geographic impact of Ming Ming Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ming Ming Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ming Ming Wen more than expected).

Fields of papers citing papers by Ming Ming Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ming Ming Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ming Ming Wen. The network helps show where Ming Ming Wen may publish in the future.

Co-authorship network of co-authors of Ming Ming Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Ming Ming Wen. A scholar is included among the top collaborators of Ming Ming Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ming Ming Wen. Ming Ming Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wen, Ming Ming, et al.. (2025). Sustainable nanophytosome-based therapies against multidrug-resistant Escherichia coli in urinary tract infections: an in Vitro and in vivo study. Journal of Nanobiotechnology. 23(1). 174–174. 1 indexed citations
2.
Hamdan, Ahmed M., et al.. (2025). Psychological challenges faced community pharmacists during COVID-19 pandemic: A cross-sectional study. Pharmacy Practice. 23(1). 1–10. 1 indexed citations
3.
El‐Zahaby, Sally A., et al.. (2024). Eco-friendly Nanostructured Liquid Crystals Loaded with Clove Oil as a Sustainable Approach for Managing Infected Burn Wounds. AAPS PharmSciTech. 26(1). 15–15. 5 indexed citations
5.
6.
Wen, Ming Ming, et al.. (2021). Nanophyto-gel against multi-drug resistant Pseudomonas aeruginosa burn wound infection. Drug Delivery. 28(1). 463–477. 36 indexed citations
7.
Wen, Ming Ming, et al.. (2020). A Nanoparticles based Microbiological Study on the Effect of Rosemary and Ginger Essential Oils against Klebsiella pneumoniae.. The Open Microbiology Journal. 14(1). 205–212. 15 indexed citations
8.
Wen, Ming Ming, et al.. (2017). Ketoprofen-loaded Eudragit electrospun nanofibers for the treatment of oral mucositis. International Journal of Nanomedicine. Volume 12. 2335–2351. 84 indexed citations
9.
Farid, Ragwa M. & Ming Ming Wen. (2016). Promote Recurrent Aphthous Ulcer Healing with Low Dose Prednisolone Bilayer Mucoadhesive Buccal Film. Current Drug Delivery. 14(1). 123–135. 13 indexed citations
10.
Wen, Ming Ming. (2016). Getting miRNA Therapeutics into the Target Cells for Neurodegenerative Diseases: A Mini-Review. Frontiers in Molecular Neuroscience. 9. 129–129. 74 indexed citations
11.
Wen, Ming Ming, Noha S. El-Salamouni, Wessam M. El-Refaie, et al.. (2016). Nanotechnology-based drug delivery systems for Alzheimer's disease management: Technical, industrial, and clinical challenges. Journal of Controlled Release. 245. 95–107. 156 indexed citations
12.
Deng, Xiaolin, et al.. (2016). [Magnetic Resonance Imaging Tracing the Biodistribution of SPIO-shRNA Molecular Probe in vivo].. PubMed. 47(4). 516–521. 1 indexed citations
13.
Wen, Ming Ming, et al.. (2016). QUALITY EVALUATION AND SURVEY OF THE ESSENTIAL NEED FOR DRUG INFORMATION CENTERS. International Journal of Pharmacy and Pharmaceutical Sciences. 8(11). 137–137. 1 indexed citations
14.
Wen, Ming Ming, Ragwa M. Farid, & Abeer Ahmed Kassem. (2014). Nano-proniosomes enhancing the transdermal delivery of mefenamic acid. Journal of Liposome Research. 24(4). 280–289. 46 indexed citations
15.
El-Habashy, Salma E., Chris E. Adkins, Ming Ming Wen, et al.. (2014). Novel Treatment Strategies for Brain Tumors and Metastases. Pharmaceutical Patent Analyst. 3(3). 279–296. 18 indexed citations
16.
Wen, Ming Ming. (2012). Advances and challenges in the dosage form design for the treatment of Parkinson's disease.. PubMed. 14(79). 369–77. 2 indexed citations
17.
Wen, Ming Ming, Amal H. El‐Kamel, & Said A. Khalil. (2011). Systemic enhancement of papaverine transdermal gel for erectile dysfunction. Drug Development and Industrial Pharmacy. 38(8). 912–922. 18 indexed citations
18.
Wen, Ming Ming. (2011). Olfactory targeting through intranasal delivery of biopharmaceutical drugs to the brain: current development.. PubMed. 11(61). 497–503. 37 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026